II
IDXX icon

IFM Investors’s Idexx Laboratories IDXX Stock Holding History

IFM Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
19,244
+1,187
+7% +$666K 0.07% 256
2026
Q1 		$10.1M Buy
18,057
+586
+3% +$376K 0.08% 227
2025
Q4 		$11.8M Buy
17,471
+298
+2% +$203K 0.1% 184
2025
Q3 		$10.9M Sell
17,173
-270
-2% -$164K 0.1% 189
2025
Q2 		$9.36M Sell
17,443
-3
-0% -$1.44K 0.09% 208
2025
Q1 		$7.33M Hold
17,446
– – 0.08% 242
2024
Q4 		$7.21M Sell
17,446
-1,501
-8% -$658K 0.07% 251
2024
Q3 		$9.57M Buy
18,947
+56
+0.3% +$27.2K 0.09% 210
2024
Q2 		$9.2M Buy
18,891
+32
+0.2% +$16.1K 0.09% 204
2024
Q1 		$10.2M Sell
18,859
-156
-0.8% -$85.3K 0.11% 179
2023
Q4 		$10.6M Sell
19,015
-283
-1% -$133K 0.13% 163
2023
Q3 		$8.44M Buy
19,298
+1,149
+6% +$573K 0.11% 182
2023
Q2 		$9.11M Buy
18,149
+95
+0.5% +$45.5K 0.12% 172
2023
Q1 		$9.03M Buy
18,054
+2,007
+13% +$960K 0.14% 151
2022
Q4 		$6.55M Buy
16,047
+1,803
+13% +$700K 0.11% 206
2022
Q3 		$4.64M Hold
14,244
– – 0.08% 257
2022
Q2 		$5M Buy
14,244
+1,090
+8% +$444K 0.09% 241
2022
Q1 		$7.2M Buy
13,154
+1,652
+14% +$869K 0.11% 187
2021
Q4 		$7.57M Sell
11,502
-87
-0.8% -$54.6K 0.14% 138
2021
Q3 		$7.21M Sell
11,589
-35
-0.3% -$23.5K 0.15% 130
2021
Q2 		$7.34M Buy
11,624
+2,420
+26% +$1.34M 0.15% 140
2021
Q1 		$4.5M Buy
9,204
+1,015
+12% +$509K 0.12% 163
2020
Q4 		$4.09M Buy
8,189
+1,184
+17% +$530K 0.13% 151
2020
Q3 		$2.75M Buy
7,005
+588
+9% +$217K 0.12% 169
2020
Q2 		$2.12M Sell
6,417
-2,181
-25% -$631K 0.11% 183
2020
Q1 		$2.07M Sell
8,598
-323
-4% -$84.3K 0.09% 215
2019
Q4 		$2.33M Sell
8,921
-368
-4% -$97K 0.08% 253
2019
Q3 		$2.53M Buy
9,289
+3,493
+60% +$972K 0.09% 230
2019
Q2 		$1.6M Buy
5,796
+68
+1% +$16.8K 0.09% 239
2019
Q1 		$1.28M Buy
5,728
+704
+14% +$145K 0.08% 253
2018
Q4 		$935K Buy
5,024
+541
+12% +$111K 0.08% 263
2018
Q3 		$1.12M Buy
4,483
+612
+16% +$149K 0.08% 242
2018
Q2 		$844K Buy
3,871
+1,291
+50% +$266K 0.08% 269
2018
Q1 		$494K Buy
2,580
+232
+10% +$42.8K 0.07% 312
2017
Q4 		$367K Buy
2,348
+180
+8% +$28.3K 0.06% 396
2017
Q3 		$337K Buy
2,168
+135
+7% +$21.3K 0.06% 394
2017
Q2 		$328K Buy
+2,033
New +$330K 0.06% 394

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

IFM Investors's IDXX Position: Q2 2026 in Review

IFM Investors increased its Idexx Laboratories (IDXX) stake by 6.6% in Q2 2026, buying an estimated $666K and bringing the position to 19,244 shares worth $10.1M. The position accounts for 0.07% of the portfolio, ranked #256.

IFM Investors first reported a position in IDXX in Q2 2017 and has held it in 37 quarters since. The position peaked at $11.8M in Q4 2025. 312 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • IFM Investors held 19,244 shares of Idexx Laboratories worth $10.1M as of Q2 2026.
  • IFM Investors bought 1,187 Idexx Laboratories shares in Q2 2026, an estimated $666K.
  • Idexx Laboratories made up 0.07% of IFM Investors's portfolio in Q2 2026, its #256 holding.
  • IFM Investors first reported a position in Idexx Laboratories in Q2 2017 and has held it in 37 quarters since.
  • IFM Investors's Idexx Laboratories position peaked at $11.8M in Q4 2025.
  • 312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.